10-05-2024
|
|
|
Ortin Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
|
|
07-05-2024
|
|
|
ORTINLAB:The Exchange had sought clarification from Ortin Laboratories Limited with respect to announcement dated 13-Feb-2024, regarding " Ortin Laboratories Limited has informed the Exchange regarding appointment of Directors On basis of above the Company is required to clarify following:ᅡᅠ1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority. The response of the Company is attached. |
|
|
|
29-04-2024
|
|
|
ORTINLAB:The Exchange has sought clarification from Ortin Laboratories Limited with respect to announcement dated 13-Feb-2024, regarding " Ortin Laboratories Limited has informed the Exchange regarding appointment of Directorsï¿‚ï¾ On basis of above the Company is required to clarify following:ᅡᅠ1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority. The response of the Company is awaited. |
|
|
|
16-04-2024
|
|
|
Ortin Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
|
|
11-04-2024
|
|
|
Ortin Laboratories Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on April 11, 2024. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. |
|
|
|
06-04-2024
|
|
|
Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ortin Laboratories Limited has submitted their response. |
|
|
|
05-04-2024
|
|
|
Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
|
|
|
05-04-2024
|
|
|
ORTIN LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window |
|
|
|
02-04-2024
|
|
|
Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
20-03-2024
|
|
|
Ortin Laboratories Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on April 11, 2024 |
|
|
|
|